newsfilter
← Latest News
GlobeNewswire·

Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer

MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance Officer. Mr.